Amrutanjan Health Care Share PriceAmrutanjan Health Care

₹616.15
1.55 (0.25%)
As on 30 September, 2023 | 17:35 BSE: 590006 NSE: AMRUTANJANISIN: INE098F01031

Amrutanjan Health Care Performance

Day Range

  • Low 613.15
  • High 624.85
616.15

52 Week Range

  • Low 554.05
  • High 775.45
616.15
  • Open Price614.6
  • Previous Close614.6
  • Volume37601

Start SIP in Amrutanjan Health Care

Start SIP

Amrutanjan Health Care Share Price

  • Over 1 Month 1.21%
  • Over 3 Month -7.75%
  • Over 6 Month 7.22%
  • Over 1 Year -13.9%

Amrutanjan Health Care Key Statistics

P/E Ratio 41.7
PEG Ratio -1.6
Market Cap Cr 1,801
Price to Book Ratio 6.2
EPS 13.6
Dividend 0.7
Relative Strength Index 40.93
Money Flow Index 32.62
MACD Signal -0.78
Average True Range 14.04

Amrutanjan Health Care Investment Rating

  • Master Rating:
  • Amrutanjan Health Care has an operating revenue of Rs. 386.54 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 92 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Amrutanjan Health Care Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 781009811171107
Operating Expenses Qtr Cr 718785956890
Operating Profit Qtr Cr 7131216316
Depreciation Qtr Cr 111211
Interest Qtr Cr 000000
Tax Qtr Cr 244525
Net Profit Qtr Cr 7131113415
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 394421
Operating Expenses Annual Cr 335326
Operating Profit Annual in Cr 4479
Depreciation Cr 54
Interest Annual Cr 00
Tax Annual Cr 1423
Net Profit Annual Cr 4067
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 52
Cash from Investing Activity Annual Cr -36
Cash from Financing Annual Activity Cr -17
Net Cash Flow Annual Cr -1
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 291265
Fixed Assets Annual Cr 5046
Total Non Current Assets Annual Cr 10375
Total Current Assets Annual Cr 260275
Total Assets Annual Cr 362350
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9991
ROE Annual % 1425
ROCE Annual % 1833
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1623
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Amrutanjan Health Care Technicals

EMA & SMA

Current Price
₹616.15
1.55 (0.25%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹628.87
  • 50 Day
  • ₹633.41
  • 100 Day
  • ₹637.85
  • 200 Day
  • ₹655.77
  • 20 Day
  • ₹632.3
  • 50 Day
  • ₹632.77
  • 100 Day
  • ₹635.31
  • 200 Day
  • ₹646.75

Amrutanjan Health Care Resistance and Support

PIVOT
₹618.05
Resistance
First Resistance ₹622.96
Second Resistance ₹629.75
Third Resistance ₹634.65
RSI 40.93
MFI 32.62
MACD Single Line -0.78
MACD -2.54
Support
First Resistance ₹611.25
Second Resistance ₹606.35
Third Resistance ₹599.55

Amrutanjan Health Care Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 40,842 1,387,811 33.98
Week 29,089 1,078,344 37.07
1 Month 45,425 2,290,312 50.42
6 Month 74,402 2,605,565 35.02

Amrutanjan Health Care Result Highlights

Amrutanjan Health Care Synopsis

NSE-Medical-Generic Drugs

Amrutanjan Health Ca is involved in the business activities of Manufacture of `ayurvedic’ or `unani’ pharmaceutical preparation. Company’s Total Operating Revenue is Rs. 379.64 Cr. and Equity Capital is Rs. 2.92 Cr. for the Year ended 31/03/2023. Amrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1936PLC000017 and registration number is 000017.
Market Cap 1,801
Sales 387
Shares in Float 1.46
No of funds 28
Yield 0.75
Book Value 6.19
U/D Vol ratio 0.6
LTDebt / Equity
Alpha -0.03
Beta 0.38

Amrutanjan Health Care

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 50.04%50.04%50.02%50.02%
Mutual Funds 6.93%6.92%6.14%6.06%
Foreign Portfolio Investors 0.69%0.68%0.76%0.87%
Financial Institutions/ Banks 0.09%0.09%0.09%0.09%
Individual Investors 35.03%35.38%35.99%36.09%
Others 7.22%6.89%7%6.87%

Amrutanjan Health Care Management

Name Designation
Mr. S Sambhu Prasad Chairman & Managing Director
Dr. Pasumarthi S N Murthi Non Executive Director
Mr. G Raghavan Ind. Non-Executive Director
Dr.(Ms.) Marie Shiranee Pereira Ind. Non-Executive Director
Dr. S Vydeeswaran Ind. Non-Executive Director
Mr. Raja Venkataraman Ind. Non-Executive Director
Mr. S Muralidharan Ind. Non-Executive Director

Amrutanjan Health Care Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Amrutanjan Health Care Corporate Action

Date Purpose Remarks
2023-08-02 Quarterly Results
2023-06-30 Buy Back of Shares
2023-05-30 Audited Results & Final Dividend (Revised) per share(55%)First Interi
2023-02-14 Quarterly Results & Interim Dividend
2022-11-04 Quarterly Results & Interim Dividend
Date Purpose Remarks
2023-09-14 FINAL Rs.2.60 per share(260%)Final Dividend
2023-02-24 INTERIM Rs.1.00 per share (100%) Second Interim Dividend
2022-11-15 INTERIM Rs.1.00 per share(100%)First Interim Dividend
2022-02-21 INTERIM Rs.1.00 per share(100%)Second Interim Dividend
2021-11-17 INTERIM Re.1.00 per share (100%) First Interim Dividend

Amrutanjan Health Care MF Shareholding

Name Amount(cr)
DSP Small Cap Fund Regular Plan Growth 12083
Sundaram Small Cap Fund - Regular Plan - Growth Option 2582
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Amrutanjan Health Care FAQs

What is Share Price of Amrutanjan Health Care ?

Amrutanjan Health Care share price is ₹616 As on 30 September, 2023 | 17:21

What is the Market Cap of Amrutanjan Health Care ?

The Market Cap of Amrutanjan Health Care is ₹1801 Cr As on 30 September, 2023 | 17:21

What is the P/E ratio of Amrutanjan Health Care ?

The P/E ratio of Amrutanjan Health Care is 41.7 As on 30 September, 2023 | 17:21

What is the PB ratio of Amrutanjan Health Care ?

The PB ratio of Amrutanjan Health Care is 6.2 As on 30 September, 2023 | 17:21

Q2FY23